141 related articles for article (PubMed ID: 12935987)
1. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M
Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987
[No Abstract] [Full Text] [Related]
2. Prognostic value of minimal residual disease monitoring in acute myeloid leukemia patients with t(9;11)(p22;q23).
Tobal K
Haematologica; 2005 Dec; 90(12):1586A. PubMed ID: 16330423
[No Abstract] [Full Text] [Related]
3. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
[TBL] [Abstract][Full Text] [Related]
4. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
[TBL] [Abstract][Full Text] [Related]
5. Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
Ferrara F; Schiavone EM; Palmieri S; Mele G; Pocali B; Scalia G; Morabito P; Sebastio L; Del Vecchio L
Hematol J; 2003; 4(3):218-21. PubMed ID: 12764355
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
[No Abstract] [Full Text] [Related]
7. Possibility of remission induction in acute myeloid leukemia by granulocyte colony-stimulating factor.
Muroi K; Tsunoda S; Yoshida M; Sakamoto S; Miura Y
Int J Hematol; 1993 Aug; 58(1-2):129-30. PubMed ID: 7693025
[No Abstract] [Full Text] [Related]
8. Strategies in the treatment of acute myeloid leukemia.
Lowenberg B
Haematologica; 2004 Sep; 89(9):1029-32. PubMed ID: 15377460
[No Abstract] [Full Text] [Related]
9. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
Blum W; Mrózek K; Ruppert AS; Carroll AJ; Rao KW; Pettenati MJ; Anastasi J; Larson RA; Bloomfield CD
Cancer; 2004 Sep; 101(6):1420-7. PubMed ID: 15368330
[TBL] [Abstract][Full Text] [Related]
10. Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21).
Albano F; Specchia G; Anelli L; Liso A; Zagaria A; Santoro A; Mirto S; Liso V; Rocchi M
Leuk Res; 2005 Jul; 29(7):855-8. PubMed ID: 15927680
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.
Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W
Leuk Res; 2007 Oct; 31(10):1383-8. PubMed ID: 17420048
[TBL] [Abstract][Full Text] [Related]
12. [Tetraploid clones characterized by double 8;21 translocations in two patients with acute myeloid leukemia].
Xue Y; Pan Y; Liu Z; Guo Y; Xie X
Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):240-2. PubMed ID: 15622754
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
15. Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature.
Müller CI; Trepel M; Kunzmann R; Lais A; Engelhardt R; Lübbert M
Eur J Haematol; 2004 Jul; 73(1):62-6. PubMed ID: 15182340
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
Cripe LD; Rader K; Tallman MS; Gordon MS; Paietta E; Bennett J; Neuberg D; Litzow MR; O'brien TE; Rowe JM
Leuk Res; 2006 Jul; 30(7):823-7. PubMed ID: 16413056
[TBL] [Abstract][Full Text] [Related]
18. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
[No Abstract] [Full Text] [Related]
19. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of acute myeloid leukemia.
Caligiuri MA; Strout MP; Gilliland DG
Semin Oncol; 1997 Feb; 24(1):32-44. PubMed ID: 9045303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
